¥22.53 ($3.36)

+0.23 (+1.03%)

SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · ¥14.3B mcap · 353M float · 1.31% daily turnover

Revenue

$4.2B -4.9% ▼

5Y CAGR: +11.6%

Gross Profit

$2.8B -1.5% ▼

5Y CAGR: +11.6%

Operating Income

$1.0B -0.8% ▼

5Y CAGR: +12.2%

Net Income

$906M +15.0% ▲

5Y CAGR: +13.8%

EPS (Diluted)

$1.43 +14.4% ▲

5Y CAGR: +13.8%

EBITDA

$1.2B +1.0% ▲

5Y CAGR: +12.8%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$2.9B	$3.9B	$4.6B	$4.4B	$4.2B
YoY Growth	+17.7%	+35.2%	+17.2%	-2.6%	-4.9%
Cost of Revenue	$1.0B	$1.4B	$1.6B	$1.6B	$1.5B
Gross Profit	$1.8B	$2.5B	$2.9B	$2.8B	$2.8B
Gross Margin	64.3%	64.4%	63.8%	63.2%	65.4%
R&D Expenses	$88M	$100M	$141M	$130M	$0
SG&A Expenses	$1.2B	$1.7B	$1.9B	$1.7B	$1.5B
Operating Expenses	$1.2B	$1.8B	$2.0B	$1.8B	$1.6B
Operating Income	$626M	$748M	$913M	$1.0B	$1.0B
Operating Margin	21.8%	19.3%	20.0%	23.2%	24.2%
Interest Expense	$4M	$5M	$8M	$2M	$3M
Income Before Tax	$623M	$753M	$916M	$1.0B	$1.2B
Tax Expense	$92M	$107M	$129M	$165M	$225M
Net Income	$506M	$598M	$719M	$788M	$906M
Net Margin	17.6%	15.4%	15.8%	17.8%	21.5%
EPS (Diluted)	$0.80	$0.96	$1.14	$1.25	$1.43
EBITDA	$626M	$747M	$971M	$1.0B	$1.2B
Shares Outstanding	632M	624M	632M	631M	634M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$799M	$1.5B	$1.2B	$957M	$792M	$1.3B	$1.0B	$896M
Cost of Revenue	$281M	$673M	$376M	$329M	$290M	$466M	$330M	$326M
Gross Profit	$519M	$790M	$808M	$628M	$502M	$821M	$706M	$570M
Gross Margin	64.9%	54.0%	68.2%	65.6%	63.4%	63.8%	68.1%	63.6%
R&D Expenses	$13M	$53M	$27M	$40M	$30M	$56M	$29M	$16M
SG&A Expenses	$324M	$532M	$454M	$280M	$286M	$507M	$336M	$303M
Operating Expenses	$328M	$569M	$449M	$286M	$284M	$540M	$373M	$337M
Operating Income	$191M	$221M	$359M	$342M	$218M	$102M	$332M	$233M
Operating Margin	23.9%	15.1%	30.3%	35.7%	27.5%	7.9%	32.1%	26.0%
Interest Expense	$91K	$1M	$233K	$251K	$233K	$1M	$285K	$441K
Income Before Tax	$188M	$218M	$359M	$344M	$220M	$289M	$360M	$279M
Tax Expense	$28M	$41M	$52M	$92M	$37M	$44M	$49M	$48M
Net Income	$146M	$154M	$285M	$237M	$161M	$223M	$288M	$203M
Net Margin	18.2%	10.5%	24.1%	24.8%	20.3%	17.4%	27.8%	22.7%
EPS (Diluted)	$0.23	$0.25	$0.45	$0.38	$0.26	$0.36	$0.46	$0.32
EBITDA	$256M	$173M	$376M	$304M	$254M	$146M	$332M	$272M
Shares Outstanding	626M	627M	633M	627M	624M	480M	629M	631M

600750.SS SHH